查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387372

花粉症市场报告：到 2030 年的趋势、预测和竞争分析

Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

花粉症趋势和预测

预计到 2030 年，全球花粉症市场将达到 72 亿美元，2024 年至 2030 年年复合成长率为 4.5%。该市场的主要驱动力是过敏发生率的增加、过敏及其管理意识的提高以及持续的技术进步。由于食品、吸入剂和药品市场的商机，全球花粉症市场的未来充满希望。

花粉症市场洞察

Lucintel 表示，由于皮质类固醇的功效、安全性和可用性，在预测期内将继续成为最大的市场。

在这个市场中，由于呼吸道过敏的高成长，吸入器仍将是最大的细分市场。

由于花粉症的高发生率和医疗基础设施未得到满足，预计亚太地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球花粉症市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球花粉症市场趋势（2018-2023）与预测（2024-2030）
  • 按药物类别分類的全球花粉症市场
    • 抗组织胺药
    • 鼻减充血剂
    • 皮质类固醇
    • 肥大细胞稳定剂
    • 白三烯抑制剂
    • 鼻用抗胆碱能药物
    • 免疫调节剂
    • 自动注射肾上腺素
    • 免疫疗法
  • 按产品类型分類的全球花粉症市场
    • 装置
    • 消耗品
    • 服务
  • 按过敏原类型分類的全球花粉症市场
    • 食品
    • 吸入
    • 药品
    • 其他的
  • 按最终用途分類的全球花粉症市场
    • 诊断实验室
    • 医院
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 按地区分類的全球花粉症市场
  • 北美花粉症市场
  • 欧洲花粉症市场
  • 亚太花粉症市场
  • 其他地区花粉症市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按药物类别分類的全球花粉症市场成长机会
    • 按产品类别分類的全球花粉症市场成长机会
    • 按过敏原类型分類的全球花粉症市场成长机会
    • 全球花粉症市场成长机会（依最终用途）
    • 全球花粉症市场成长机会（按地区）
  • 全球花粉症市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球花粉症市场的产能
    • 全球花粉症市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan
简介目录

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

A more than 150-page report is developed to help in your business decisions.

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto Injectable Epinephrine
  • Immunotherapy

Pollen Allergy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Pollen Allergy Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug
  • Others

Pollen Allergy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Others

Pollen Allergy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Pollen Allergy Market Insights

Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.

APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
    • 3.3.1: Antihistamines
    • 3.3.2: Decongestants
    • 3.3.3: Corticosteroids
    • 3.3.4: Mast Cell Stabilizers
    • 3.3.5: Leukotriene Inhibitors
    • 3.3.6: Nasal Anticholinergics
    • 3.3.7: Immunomodulators
    • 3.3.8: Auto injectable Epinephrine
    • 3.3.9: Immunotherapy
  • 3.4: Global Pollen Allergy Market by Product Type
    • 3.4.1: Instruments
    • 3.4.2: Consumables
    • 3.4.3: Services
  • 3.5: Global Pollen Allergy Market by Allergen Type
    • 3.5.1: Food
    • 3.5.2: Inhaled
    • 3.5.3: Drug
    • 3.5.4: Others
  • 3.6: Global Pollen Allergy Market by End Use
    • 3.6.1: Diagnostic Laboratories
    • 3.6.2: Hospitals
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pollen Allergy Market by Region
  • 4.2: North American Pollen Allergy Market
    • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.3: European Pollen Allergy Market
    • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.4: APAC Pollen Allergy Market
    • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.5: ROW Pollen Allergy Market
    • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
    • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
    • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
    • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
  • 6.2: Emerging Trends in the Global Pollen Allergy Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ALK-Abello
  • 7.2: Circassia
  • 7.3: DBV Technologies
  • 7.4: Genentech
  • 7.5: GlaxoSmithKline
  • 7.6: HAL Allergy
  • 7.7: Johnson & Johnson
  • 7.8: Meda AB
  • 7.9: Merck & Co
  • 7.10: Mylan